American Conference on Pharmacometrics (ACoP) 2026 Conference

The Food and Drug Administration is forecasting a requirement for the American Conference on Pharmacometrics (ACoP) 2026 Conference. This initiative is designed to keep FDA personnel at the forefront of innovation in model-informed drug development by providing access to emerging scientific approaches and engagement with experts from industry, academia, and regulatory agencies. The primary goal is to acquire practical knowledge, tools, and professional connections that directly support the agency's organizational objectives. Classified under NAICS code 611430, this forecast is managed by the Food and Drug Administration. While a specific contracting officer has not yet been named, the Cder Acquisition Liaison serves as the program point of contact for inquiries. The opportunity is currently listed as a forecast, indicating the agency's intent to pursue these scientific and professional development goals for the 2026 event.